Last reviewed · How we verify
Investigational OTC Cream
Unknown; insufficient public data on the specific mechanism of this investigational OTC cream.
At a glance
| Generic name | Investigational OTC Cream |
|---|---|
| Sponsor | Procter and Gamble |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
This is listed as an investigational OTC (over-the-counter) cream from Procter and Gamble, but no publicly available information specifies its active ingredient, molecular target, or mechanism of action. Without additional details, the mechanism cannot be reliably determined.
Approved indications
Common side effects
Key clinical trials
- Verifying the Effectiveness of the NUsurface® System (NA)
- The VENUS Clinical Study (Verifying the Effectiveness of the NUsurface® System) (NA)
- Oral Health-related Quality of Life and Masticatory Function After Using Denture Adhesive and Denture Liner (PHASE3)
- Perianal Maceration in Pediatric Ostomy Closure Patients (NA)
- 8-Week Atopic Dermatitis (AD) Treatment Study (PHASE3)
- Trial to Determine the Therapeutic Benefit of an OTC Cream on Dry, Itchy Skin of Adults and Children With Eczema (PHASE2)
- Efficacy and Tolerability of New Topical Formulations in Subjects With Atopic Dermatitis (PHASE4)
- Human Testing of an Over-the-Counter (OTC) Cream in Children With Eczema (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Investigational OTC Cream CI brief — competitive landscape report
- Investigational OTC Cream updates RSS · CI watch RSS
- Procter and Gamble portfolio CI